BioSpace News Archive

Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today issued the following letter to stockholders in conjunction with the 2021 Abeona Therapeutics Annual Meeting of Stockholders to be held today, May 26, 2021:

SDX is KemPharm’s proprietary prodrug of d-methylphenidate (d-MPH) and the primary active pharmaceutical ingredient (API) in AZSTARYS™

Thoma Bravo , a leading private equity investment firm focused on the software and technology-enabled services sector, today announced that it has reached an agreement to acquire Greenphire , the global leader in financial lifecycle management software for clinical trials, from The Riverside Company.

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez , the company’s president and chief executive officer, is scheduled to present a company overview at the Jefferies Virtual Healthcare Conference on Wednesday, June 2, 2021 at 1:00 p.m. Eastern Time .

Innova Medical Group, the world’s largest provider of rapid antigen tests, has announced an initial investment in South Wales to start producing millions of COVID lateral flow tests per day in the UK, with additional investments to follow later this year to further expand production capacity.

X4 Pharmaceuticals, Inc. announced it will be hosting a conference call and webcast to present and discuss initial efficacy and safety data from the ongoing Phase 1b clinical trial of its lead clinical candidate, mavorixafor, in combination with ibrutinib, in Waldenström’s Macroglobulinemia patients with MYD88 and CXCR4 mutations.

Kronos Bio, Inc., a company dedicated to transforming the lives of those affected by cancer, announced that members of the management team will participate in fireside chats at the following investor conferences:

Metacrine, Inc. (NASDAQ:MTCR), a clinical-stage biopharmaceutical company pioneering differentiated therapies for patients with liver and gastrointestinal diseases, today announced that Preston Klassen, M.D., MHS, president and chief executive officer, will present virtually at the 2021 Jefferies Healthcare Conference at 11:00 a.m. ET on Friday, June 4, 2021

Monopar Therapeutics Inc. and NorthStar Medical Radioisotopes, LLC, announced the filing of a provisional composition of matter patent titled “Urokinase Plasminogen Activator Receptor-Targeted Radiopharmaceutical” covering a radiotherapeutic consisting of Monopar’s proprietary antibody MNPR-101 bound to Actinium-225 via the metal binding agent PCTA.

Arbutus Biopharma Corporation, a clinical-stage biopharmaceutical company primarily focused on developing a cure for people with chronic hepatitis B virus infection, as well as therapies to treat coronaviruses, announced that the Company will participate in the following upcoming investor conferences